Perrigo (PRGO) Receivables - Other (2015 - 2025)

Perrigo (PRGO) posted quarterly Receivables - Other of -$98.0 million for Q1 2025, down 217.51% quarter-over-quarter from $83.4 million in Q4 2021.

Perrigo (PRGO) Receivables - Other (2015 - 2025) Analysis & Trends

Perrigo (PRGO) has reported Receivables - Other for 3 consecutive years, with -$98.0 million the latest figure, recorded in Q1 2025.

In Q1 2025, Receivables - Other changed N/A year-over-year to -$98.0 million; the TTM figure through Oct 2021 stood at $83.4 million (changed N/A YoY), while the FY2024 annual figure was -$98.0 million, changed N/A from the prior year.
Receivables - Other fell to -$98.0 million in Q1 2025 per PRGO's latest filing, from $83.4 million in the prior quarter.
Across five years, Receivables - Other topped out at $83.4 million in Q4 2021 and bottomed at -$98.0 million in Q1 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	43.98 Bn	43.02 Bn	-
2	Teva Pharmaceutical Industries	43.07 Bn	39.42 Bn	2.15 Bn
3	Zoetis	31.53 Bn	29.85 Bn	1.05 Bn
4	Takeda Pharmaceutical	28.60 Bn	22.80 Bn	5.10 Bn
5	United Therapeutics	22.13 Bn	19.47 Bn	683.80 Mn
6	Viatris	18.75 Bn	17.86 Bn	1.46 Bn
7	Neurocrine Biosciences	15.53 Bn	15.14 Bn	935.80 Mn
8	Elanco Animal Health	11.69 Bn	11.16 Bn	798.00 Mn
9	Dr Reddys Laboratories	10.13 Bn	9.97 Bn	-
10	Perrigo	1.94 Bn	1.54 Bn	313.90 Mn

Download Data